Neurizon Therapeutics Limited (ASX: NUZ & NUZOA) ("Neurizon" or "the Company"), a clinical-stage biotech company advancing ...
China's virtual monopoly on the supply of many APIs could be dangerous for the security of medicine supply to Western ...
About AVT23 AVT23 is a monoclonal antibody and proposed biosimilar to Xolair ® (omalizumab). AVT23 is an investigational compound and has not received regulatory approval in any country. Biosimilarity ...
Neurizon has been buoyed by the receipt of a positive opinion from the European Medicines Agency in relation to its ...
Euronews (English) on MSN10d
Enlargement health check: Which EU hopefuls are fittest?A recent "checkup" on EU candidate countries reveals how well the nine hopefuls align with the bloc’s health standards.
The Belgian Health Care Knowledge Centre and Sciensano, in collaboration with several Belgian institutions, have launched the ...
Residents of the countries of the European Union are recommended to stock up on at least three days' worth of food in case of ...
Paris: Sanofi has announced that the European Medicines Agency has approved Dupixent (dupilumab) to treat eosinophilic ...
Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of science, technology, and medicine news ...
Dupixent approved in the EU as the first and only medicine for young children with eosinophilic esophagitisApproval based on phase 3 data showing ...
About fifteen organizations from the ePharma sector are joining forces to launch a coalition aimed at standardizing online ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback